# Rivian Automotive, Inc. / DE: financial statements, quarterly

RIVN · Nasdaq · CIK 1874178 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rivn.md) · [Financials](/companies/rivn/financials.md) · [Filings](/companies/rivn/filings.md) · [Insiders](/companies/rivn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rivn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,337](/filings/0001874178-24-000063.md) | [1,315 d](/filings/0001874178-26-000008.md) | [1,204](/filings/0001874178-25-000026.md) | [1,158](/filings/0001874178-25-000036.md) | [874](/filings/0001874178-25-000052.md) | [1,734 d](/filings/0001874178-26-000008.md) | [1,240](/filings/0001874178-26-000035.md) | [1,303](/filings/0001874178-26-000054.md) | [1,558](/filings/0001874178-25-000052.md) | [1,286 d](/filings/0001874178-26-000008.md) | [1,381](/filings/0001874178-26-000035.md) | [1,658](/filings/0001874178-26-000054.md) |
| Cost of revenue | $m | [1,814](/filings/0001874178-24-000063.md) | [1,921 d](/filings/0001874178-26-000008.md) | [1,731](/filings/0001874178-25-000026.md) | [1,609](/filings/0001874178-25-000036.md) | [1,266](/filings/0001874178-25-000052.md) | [1,564 d](/filings/0001874178-26-000008.md) | [1,034](/filings/0001874178-26-000035.md) | [1,509](/filings/0001874178-26-000054.md) | [1,534](/filings/0001874178-25-000052.md) | [1,166 d](/filings/0001874178-26-000008.md) | [1,262](/filings/0001874178-26-000035.md) | [1,479](/filings/0001874178-26-000054.md) |
| Gross profit | $m | [(477)](/filings/0001874178-24-000063.md) | [(606) d](/filings/0001874178-26-000008.md) | [(527)](/filings/0001874178-25-000026.md) | [(451)](/filings/0001874178-25-000036.md) | [(392)](/filings/0001874178-25-000052.md) | [170 d](/filings/0001874178-26-000008.md) | [206](/filings/0001874178-26-000035.md) | [(206)](/filings/0001874178-26-000054.md) | [24.0](/filings/0001874178-25-000052.md) | [120 d](/filings/0001874178-26-000008.md) | [119](/filings/0001874178-26-000035.md) | [179](/filings/0001874178-26-000054.md) |
| Research and development | $m | [529](/filings/0001874178-24-000063.md) | [526 d](/filings/0001874178-26-000008.md) | [461](/filings/0001874178-25-000026.md) | [428](/filings/0001874178-25-000036.md) | [350](/filings/0001874178-25-000052.md) | [374 d](/filings/0001874178-26-000008.md) | [381](/filings/0001874178-26-000035.md) | [410](/filings/0001874178-26-000054.md) | [453](/filings/0001874178-25-000052.md) | [424 d](/filings/0001874178-26-000008.md) | [458](/filings/0001874178-26-000035.md) | [466](/filings/0001874178-26-000054.md) |
| Selling, general and administrative | $m | [434](/filings/0001874178-24-000063.md) | [449 d](/filings/0001874178-26-000008.md) | [496](/filings/0001874178-25-000026.md) | [496](/filings/0001874178-25-000036.md) | [427](/filings/0001874178-25-000052.md) | [457 d](/filings/0001874178-26-000008.md) | [480](/filings/0001874178-26-000035.md) | [498](/filings/0001874178-26-000054.md) | [554](/filings/0001874178-25-000052.md) | [529 d](/filings/0001874178-26-000008.md) | [542](/filings/0001874178-26-000035.md) | [549](/filings/0001874178-26-000054.md) |
| Operating income | $m | [(1,440)](/filings/0001874178-24-000063.md) | [(1,581) d](/filings/0001874178-26-000008.md) | [(1,484)](/filings/0001874178-25-000026.md) | [(1,375)](/filings/0001874178-25-000036.md) | [(1,169)](/filings/0001874178-25-000052.md) | [(661) d](/filings/0001874178-26-000008.md) | [(655)](/filings/0001874178-26-000035.md) | [(1,114)](/filings/0001874178-26-000054.md) | [(983)](/filings/0001874178-25-000052.md) | [(833) d](/filings/0001874178-26-000008.md) | [(881)](/filings/0001874178-26-000035.md) | [(836)](/filings/0001874178-26-000054.md) |
| Interest expense | $m | [55.0](/filings/0001874178-23-000058.md) | [73.0 d](/filings/0001874178-24-000014.md) | [75.0](/filings/0001874178-24-000042.md) | [75.0](/filings/0001874178-25-000036.md) | [87.0](/filings/0001874178-25-000052.md) | [81.0 d](/filings/0001874178-26-000008.md) | [72.0](/filings/0001874178-26-000035.md) | [69.0](/filings/0001874178-26-000054.md) | [69.0](/filings/0001874178-25-000052.md) | [64.0 d](/filings/0001874178-26-000008.md) | [65.0](/filings/0001874178-26-000035.md) | [68.0](/filings/0001874178-26-000054.md) |
| Income tax | $m | [0.0](/filings/0001874178-24-000063.md) | [0.0 d](/filings/0001874178-26-000008.md) | [1.0](/filings/0001874178-25-000026.md) | [1.0](/filings/0001874178-25-000036.md) | [0.0](/filings/0001874178-25-000052.md) | [3.0 d](/filings/0001874178-26-000008.md) | [2.0](/filings/0001874178-26-000035.md) | [2.0](/filings/0001874178-26-000054.md) | [(1.0)](/filings/0001874178-25-000052.md) | [3.0 d](/filings/0001874178-26-000008.md) | [(2.0)](/filings/0001874178-26-000035.md) | [(1.0)](/filings/0001874178-26-000054.md) |
| Net income | $m | [(1,367)](/filings/0001874178-24-000063.md) | [(1,521) d](/filings/0001874178-26-000008.md) | [(1,446)](/filings/0001874178-25-000026.md) | [(1,457)](/filings/0001874178-25-000036.md) | [(1,100)](/filings/0001874178-25-000052.md) | [(744) d](/filings/0001874178-26-000008.md) | [(545)](/filings/0001874178-26-000035.md) | [(1,117)](/filings/0001874178-26-000054.md) | [(1,173)](/filings/0001874178-25-000052.md) | [(811) d](/filings/0001874178-26-000008.md) | [(416)](/filings/0001874178-26-000035.md) | [(833)](/filings/0001874178-26-000054.md) |
| Diluted EPS | $ per share | [(1.44)](/filings/0001874178-24-000063.md) | not reported | [(1.48)](/filings/0001874178-25-000026.md) | [(1.46)](/filings/0001874178-25-000036.md) | [(1.08)](/filings/0001874178-25-000052.md) | not reported | [(0.48)](/filings/0001874178-26-000035.md) | [(0.97)](/filings/0001874178-26-000054.md) | [(0.96)](/filings/0001874178-25-000052.md) | not reported | [(0.33)](/filings/0001874178-26-000035.md) | [(0.63)](/filings/0001874178-26-000054.md) |
| Basic EPS | $ per share | [(1.44)](/filings/0001874178-24-000063.md) | not reported | [(1.48)](/filings/0001874178-25-000026.md) | [(1.46)](/filings/0001874178-25-000036.md) | [(1.08)](/filings/0001874178-25-000052.md) | not reported | [(0.48)](/filings/0001874178-26-000035.md) | [(0.97)](/filings/0001874178-26-000054.md) | [(0.96)](/filings/0001874178-25-000052.md) | not reported | [(0.33)](/filings/0001874178-26-000035.md) | [(0.63)](/filings/0001874178-26-000054.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [7.9](/filings/0001874178-23-000058.md) | [7.9](/filings/0001874178-25-000007.md) | [6.0](/filings/0001874178-24-000042.md) | [5.8](/filings/0001874178-24-000057.md) | [5.4](/filings/0001874178-24-000063.md) | [5.3](/filings/0001874178-26-000008.md) | [4.7](/filings/0001874178-25-000026.md) | [4.8](/filings/0001874178-25-000036.md) | [4.4](/filings/0001874178-25-000052.md) | [3.6](/filings/0001874178-26-000054.md) | [2.8](/filings/0001874178-26-000035.md) | [3.6](/filings/0001874178-26-000054.md) |
| Current assets | $bn | [12.1](/filings/0001874178-23-000058.md) | [12.3](/filings/0001874178-25-000007.md) | [11.3](/filings/0001874178-24-000042.md) | [11.0](/filings/0001874178-24-000057.md) | [9.8](/filings/0001874178-24-000063.md) | [10.6](/filings/0001874178-26-000008.md) | [10.4](/filings/0001874178-25-000026.md) | [10.1](/filings/0001874178-25-000036.md) | [9.3](/filings/0001874178-25-000052.md) | [8.6](/filings/0001874178-26-000054.md) | [7.0](/filings/0001874178-26-000035.md) | [7.6](/filings/0001874178-26-000054.md) |
| Total assets | $bn | [16.5](/filings/0001874178-23-000058.md) | [16.8](/filings/0001874178-25-000007.md) | [15.7](/filings/0001874178-24-000042.md) | [15.4](/filings/0001874178-24-000057.md) | [14.3](/filings/0001874178-24-000063.md) | [15.4](/filings/0001874178-26-000008.md) | [15.5](/filings/0001874178-25-000026.md) | [15.6](/filings/0001874178-25-000036.md) | [15.2](/filings/0001874178-25-000052.md) | [14.9](/filings/0001874178-26-000054.md) | [14.2](/filings/0001874178-26-000035.md) | [15.1](/filings/0001874178-26-000054.md) |
| Current liabilities | $bn | [2.6](/filings/0001874178-23-000058.md) | [2.5](/filings/0001874178-25-000007.md) | [2.4](/filings/0001874178-24-000042.md) | [2.1](/filings/0001874178-24-000057.md) | [1.9](/filings/0001874178-24-000063.md) | [2.3](/filings/0001874178-26-000008.md) | [2.8](/filings/0001874178-25-000026.md) | [2.9](/filings/0001874178-25-000036.md) | [3.4](/filings/0001874178-25-000052.md) | [3.7](/filings/0001874178-26-000054.md) | [3.4](/filings/0001874178-26-000035.md) | [3.6](/filings/0001874178-26-000054.md) |
| Total liabilities | $bn | [5.9](/filings/0001874178-23-000058.md) | [7.6](/filings/0001874178-25-000007.md) | [7.7](/filings/0001874178-24-000042.md) | [8.5](/filings/0001874178-24-000057.md) | [8.4](/filings/0001874178-24-000063.md) | [8.8](/filings/0001874178-26-000008.md) | [9.3](/filings/0001874178-25-000026.md) | [9.5](/filings/0001874178-25-000036.md) | [10.1](/filings/0001874178-25-000052.md) | [10.3](/filings/0001874178-26-000054.md) | [9.8](/filings/0001874178-26-000035.md) | [10.0](/filings/0001874178-26-000054.md) |
| Long-term debt | $bn | [2.7](/filings/0001874178-23-000058.md) | [4.4](/filings/0001874178-25-000007.md) | [4.4](/filings/0001874178-24-000042.md) | [5.5](/filings/0001874178-24-000057.md) | [5.5](/filings/0001874178-24-000063.md) | [4.4](/filings/0001874178-26-000008.md) | [4.4](/filings/0001874178-25-000026.md) | [4.4](/filings/0001874178-25-000036.md) | [4.4](/filings/0001874178-25-000052.md) | [4.4](/filings/0001874178-26-000054.md) | [4.4](/filings/0001874178-26-000035.md) | [4.4](/filings/0001874178-26-000054.md) |
| Current portion of debt | $bn | [0.0](/filings/0001874178-23-000058.md) | [0.0](/filings/0001874178-24-000057.md) | [0.0](/filings/0001874178-24-000042.md) | [0.0](/filings/0001874178-24-000057.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [10.6](/filings/0001874178-24-000063.md) | [9.1](/filings/0001874178-24-000063.md) | [8.1](/filings/0001874178-24-000063.md) | [6.8](/filings/0001874178-24-000063.md) | [5.9](/filings/0001874178-24-000063.md) | [6.6](/filings/0001874178-26-000054.md) | [6.2](/filings/0001874178-26-000054.md) | [6.1](/filings/0001874178-26-000054.md) | [5.1](/filings/0001874178-25-000052.md) | [4.6](/filings/0001874178-26-000054.md) | [4.4](/filings/0001874178-26-000054.md) | [5.1](/filings/0001874178-26-000054.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(877) d](/filings/0001874178-24-000063.md) | [(1,107) d](/filings/0001874178-26-000008.md) | [(1,269)](/filings/0001874178-25-000026.md) | [(754) d](/filings/0001874178-25-000036.md) | [(876) d](/filings/0001874178-25-000052.md) | [1,183 d](/filings/0001874178-26-000008.md) | [(188)](/filings/0001874178-26-000035.md) | [64.0 d](/filings/0001874178-26-000054.md) | [26.0 d](/filings/0001874178-25-000052.md) | [(681) d](/filings/0001874178-26-000008.md) | [(703)](/filings/0001874178-26-000035.md) | [(487) d](/filings/0001874178-26-000054.md) |
| Capital expenditure | $m | [190 d](/filings/0001874178-24-000063.md) | [298 d](/filings/0001874178-26-000008.md) | [254](/filings/0001874178-25-000026.md) | [283 d](/filings/0001874178-25-000036.md) | [277 d](/filings/0001874178-25-000052.md) | [327 d](/filings/0001874178-26-000008.md) | [338](/filings/0001874178-26-000035.md) | [462 d](/filings/0001874178-26-000054.md) | [447 d](/filings/0001874178-25-000052.md) | [463 d](/filings/0001874178-26-000008.md) | [372](/filings/0001874178-26-000035.md) | [362 d](/filings/0001874178-26-000054.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [918](/filings/0001874178-23-000058.md) | [930](/filings/0001874178-24-000042.md) | [942](/filings/0001874178-24-000057.md) | [952](/filings/0001874178-24-000063.md) | [978](/filings/0001874178-25-000026.md) | [1,001](/filings/0001874178-25-000036.md) | [1,014](/filings/0001874178-25-000052.md) | [1,137](/filings/0001874178-26-000035.md) | [1,155](/filings/0001874178-26-000054.md) | [1,220](/filings/0001874178-25-000052.md) | [1,249](/filings/0001874178-26-000035.md) | [1,325](/filings/0001874178-26-000054.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.